Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

AtriCure (ATRC) Gross Profit (2016 - 2025)

AtriCure (ATRC) has disclosed Gross Profit for 16 consecutive years, with $105.3 million as the latest value for Q4 2025.

  • On a quarterly basis, Gross Profit rose 13.73% to $105.3 million in Q4 2025 year-over-year; TTM through Dec 2025 was $400.8 million, a 15.32% increase, with the full-year FY2025 number at $400.8 million, up 15.32% from a year prior.
  • Gross Profit was $105.3 million for Q4 2025 at AtriCure, up from $101.3 million in the prior quarter.
  • In the past five years, Gross Profit ranged from a high of $105.3 million in Q4 2025 to a low of $44.5 million in Q1 2021.
  • A 5-year average of $75.0 million and a median of $75.5 million in 2023 define the central range for Gross Profit.
  • Peak YoY movement for Gross Profit: soared 95.55% in 2021, then rose 12.67% in 2024.
  • AtriCure's Gross Profit stood at $55.0 million in 2021, then increased by 18.35% to $65.1 million in 2022, then increased by 22.58% to $79.8 million in 2023, then rose by 16.04% to $92.6 million in 2024, then rose by 13.73% to $105.3 million in 2025.
  • Per Business Quant, the three most recent readings for ATRC's Gross Profit are $105.3 million (Q4 2025), $101.3 million (Q3 2025), and $101.5 million (Q2 2025).